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ABSTRACT
The objective of this study was to identify the frequency of coinfection by human papillomavirus 
(HPV) and Chlamydia trachomatis (CT) in cervical lesions and relate it with immunohistochemi-
cal expression of p16INK4a and Ki67, both oncogenicity markers. A cross-sectional study with 86 
women from primary care units in southern Brazil was conducted. Cervical swabs were collected for 
HPV-DNA and CT-DNA detection, through the polymerase chain reaction technique (PCR). The 
immunohistochemical analysis was performed on biopsy cervical tissue material to identify the ex-
pression of p16INK4a and Ki67 cell cycle markers. About 83 % were positive for HPV-DNA and 19% 
had coinfection with CT-DNA. Among coinfected women, 56% expressed p16INK4a. There was 
a statistically significant association between the histological grade of the lesion and Ki67 expres-
sion. All high-grade lesions, 50% of low-grade lesions and 31% of negative biopsies expressed Ki67 
(p = 0.004). A total of 37% of coinfected women expressed both markers. In conclusion, although 
more than half of the coinfected patients have expressed p16INK4a and more than one third have ex-
pressed both markers, these results suggest no association between those variables. However, other 
studies involving larger samples are necessary to corroborate such findings. 
Keywords: epidemiology; human papillomavirus 16; biomarkers; pharmacological.
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Each year, approximately 493,000 new cas-
es of cervical cancer are diagnosed world-
wide and approximately 273,000 women die 
from the disease, making it the second most 
frequent cancer in women and the second 
leading cause of cancer-related death world-
wide among women 15 to 44 years old.1
Chlamydia trachomatis (CT) is the most 
common bacterial sexually transmitted in-
fection (STI) worldwide.2 Bacterial coinfec-
tion by CT in women with a history of HPV 
infection has been studied as a potential 
factor that contributes to the development 
of malignacies and cervical cancer. Some 
authors3 have suggested that previous CT 
infection is associated with a high risk of 
developing the disease. 
The p16INK4a is a cyclin-dependent ki-
nase inhibitor (CDK) that reduces the cell 
cycle’s speed by controlling the expression of 
E2F transcription factor. High-grade infec-
tion by HPV is involved in the carcinogenesis 
and, HPV integration in the human genome 
results in overexpression of E6 and E7 vi-
ral oncoproteins.4 E7 HPV protein inter-
acts with retinoblastoma protein (pRb) and 
neutralizes the function of these proteins, 
resulting in the release of E2F transcription 
factor of the pRb-E2F complex. E2F accu-
mulation induces p16INK4a activity.5 
Results of a study6 showed that none of 
the negative cervical tissues were positive 
for p16INK4a, while there was a constant 
and significant increase in the positiv-
ity of this marker, according to histological 
grade, where cervical intraepithelial neo-
plasia (CIN) 1 had 31% positivity, 90% in 
CIN 2 and 100% in CIN 3 and carcinomas 
(p < 0.0001). Thus, p16INK4a overexpres-
sion has consistently shown high sensitiv-
ity (84%) and specificity (98%) to detect 
the high-risk HPV with a high positive 
predictive value (97%). Ki67 monoclonal 
antibody reacts with a non-histone nuclear 
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protein that is expressed in the nucleus of proliferating 
cells through the cell cycle, except in G0 and in early 
G1 phase. Some authors7 have shown a relationship be-
tween Ki67, lesion severity or growth rate, and its util-
ity in the study of vulvar and vaginal lesions caused by 
HPV. Therefore, the determination of Ki67 seems to be a 
relevant additional and complementary examination in 
the detection and distinction of different lesion grades 
of the uterine cervix. 
It is known that high-risk HPV, through oncopro-
teins, can deplete the action of suppressor genes like the 
p53 and pRb, causing overexpression of CDK inhibitors. 
However, in coinfected patients (HPV/CT), this effect 
has not yet been studied. The purpose of this study was 
to verify p16INK4a and Ki67 immunohistochemical ex-
pression in women with positive HPV-DNA and/or CT-
DNA who attended the primary health care services in 
southern Brazil. 
This was a cross-sectional study that enrolled 86 
women from primary care services, selected from par-
ticipants of a cohort study8 started in February 2003. 
This sample included women who were tested for HPV-
DNA/CT-DNA and performed uterine cervix biopsy 
for histopathological analysis. HPV-DNA and CT-DNA 
detection in uterine cervical samples were performed 
through the PCR technique. DNA extraction from ma-
terial collected with cervical-vaginal swabs was carried 
out using the proteinase K protocol.9 The technique was 
directed to the L1 gene and the primers used were My09 
and My11. PCR conditions were described by Bauer et 
al. (1993) and Coutlée et al. (2002). For the PCR reac-
tion internal control, β-globin primers were used and 
tested in all samples.10,11 For CT-DNA, the technique was 
standardized by Becker D9 using the CTP1 and CTP2 
primers that amplify a 201pb segment of the ORF num-
ber 4 of the cryptic Chlamydia trachomatis plasmid. 
This segment is situated 2940pb from the single BamHI 
restriction site: 
CTP1 5’... TAGTAACTGCCACTTCATCA… 3’ 
CTP2 5’... TTCCCCTTGTAATTCGTTGC... 3’ 
In order to control the reactions, along with each 
DNA PCR of clinical samples, a positive control was 
tested, which consisted of a 450bp fragment corre-
sponding to Caski and Siha cells, a 201bp fragment 
corresponds to cells infected by CT; and a negative 
control with the omission of any DNA. In all tested 
samples for HPV PCR and CT PCR, multiplex PCR 
were performed using specific primers for each mi-
croorganism and primers complementing the hu-
man β-globin gene (gH20 and PC04). β-globin prim-
ers were used to verify the viability of tested DNA. 
All positive samples in the HPV-DNA screening were 
tested for high risk (HR) HPV types (HPV16, 18, 31), 
 using specific primers. The amplification conditions 
and the primers used are based on the methodology 
described by Cuzick et al.12 and are HPV-16 (5’…GC 
GAT CCT GTC TGC TTT TAT ACT AA...3’ [sense]; 
5’...AAG GCC AAC TAA ATG TCA C...3’ [antisense]) 
and the temperature was 54oC; HPV-18 (5’...TGC AGC 
ACG AAT GGC ACT GGC CTG...3’ [sense]; 5’...CAC 
GGC GAC CCT ACA AGC TAC CTG...3’ [antisense]), 
temperature was 70oC. For HPV-31 (31A 5’...TACCT-
GTGTTTCTGTTAAC...3’ [sense]; S5’...AGAAAGAC-
CTCGGAAATTG...’ [antisense])and the temperature 
was 52oC.
The paraffin blocks of biopsy material have been 
stained by the hematoxylin-eosin technique for histo-
logical classification, as follows: LSIL, HSIL, where LSIL 
category included the results with CIN1, and HSIL the 
findings with CIN 2 and 3 diagnoses. Absence of ma-
lignant alterations was reported when no abnormalities 
were observed. Later, the cases were reviewed by trained 
pathologists (MIE and LM) from Hospital de Clínicas de 
Porto Alegre (HCPA), in Porto Alegre, southern Brazil. 
The paraffin blocks were cut, deparaffinized in xy-
lene and then rehydrated. Antigen retrieval was made 
in citrate buffer pH 6.0 and, later taken to microwave 
for 20 minutes. The sections were placed at room tem-
perature and washed three times with phosphate buffer. 
After the endogenous peroxidase blockage, the sections 
were rehydrated and the slides were submitted to immu-
nohistochemistry process.
The antibodies used were p16INK4a, “Neomarkers, 
CA, USA”, clone 16P07 at a dilution of 1:75 and anti-
Ki67, “DAKO, Glostrup, Denmark”, clone MIB-1, at a 
dilution of 1:30. The p16INK4a pattern expression for 
squamous intraepithelial lesions (SIL) was graduated as 
suggested in Bulten J. et al.:13 negative (-) if none of the 
cells were colored; positive (+, weak) if the percentage of 
expressing cells ranged between 1-25%; (++, moderate) 
if the percentage ranged between 26-75%; and (+++, 
strong) if over 75% of the cells were colored, both in the 
cytoplasm and nucleus. The cells’ expression pattern was 
divided into focal if the expression was concentrated in 
some areas, and diffuse if the expression was distributed 
throughout the slide. 
Ki67 was considered positive if the cell’s nucleus 
was brown-colored. In all samples, 100 to 200 cells were 
counted and the results were expressed in percentage. 
All samples were evaluated by two pathologists (MIE e 
LM) and, when necessary, they reached a consensus.
The study outcomes were genital infection by HPV 
and/or Chlamydia trachomatis and histopathological 
diagnosis of uterine cervical lesions. The relation of 
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p16INK4a and Ki67 expressions to such outcomes were 
assessed. The independent variables studied included de-
mographic characteristics, sexual behavior, reproductive 
data and previous morbidities. Data was stored in a da-
tabase by double-entry, where 20% of the questionnaires 
were selected at random and compared to the original. 
Possible errors and discrepancies were corrected.
Chi-square test or Fisher’s exact test when indicated 
were used to compare categorical variables. Continuous 
variables were analyzed using the student’s t test and 
ANOVA. The findings with p-value ≤ 0.05 were con-
sidered statistically significant. Sensitivity, specificity 
and the positive and negative predictive values for both 
markers, using the histological results as gold-standard, 
were calculated with the correspondent 95% confidence 
intervals.
A total of 86 patients were analyzed, among which 83% 
(71/86) were positive for HPV-DNA and 19% (16/86) for 
CT-DNA. All women with positive CT-DNA were also 
positive for HPV-DNA (p = 0.06). About 40% (34/86) 
were positive for HR-HPV, among which 37% (6/34) 
were positive for CT-DNA. The most frequent HR-HPV 
was HPV-16 (50%), followed by HPV-31 (38%) and 
HPV-18 (12%). 
Table 1 describes the characteristics of women who 
presented coinfection (HPV-DNA and CT-DNA). There 
was noted a statistically significant association between 
coinfection and education level (p = 0.04). 
No statistically significant association was observed 
between lesion histology and coinfection (p = 0.75).
In the immunohistochemical analysis, 56% of the co-
infected patients expressed p16INK4a, (p = 0.38), which 
ranged from moderate to strong in approximately 37% 
and the expression pattern was diffuse in 50%. In HPV-
DNA positive biopsies, 78% expressed p16INK4a, rang-
ing from moderate to strong in 54% and with a diffuse 
pattern in 56%. Regarding histology, 83% of the high-
grade lesions expressed p16INK4a. Among low-grade 
lesions and negative biopsies, 72% and 60% expressed 
this protein, respectively (p = 0.43). 
About 50% (8/16) of coinfected women expressed 
Ki67 antibody. In HPV infected women, this antibody 
was present in 38% (p = 0.73). 
There was a statistically significant association between 
the grade of lesion histology and Ki67 expression, which was 
expressed in 100% of high-grade lesions, 50% of low-grade 
lesions and 31% of negative biopsies  (p = 0.004). 
Approximately 37% (p = 0.31) of coinfected women 
and 29% (p = 0.16) of those without coinfection expressed 
both markers. 
In relation to lesion histology among coinfected pa-
tients, the sensitivity of p16INK4a was 25% (95%CI: 
0.7-49.3%), the specificity, 72.9% (95%CI: 61.7- 84%), 
Table 1. Characteristics of women coinfected by HPV 
and CT
Variables                   Coinfection
  Yes n (%)  No n (%) p-value*
Age 
	 ≤	35	years		 7	(44)	 29	(41)	  
 > 35 years  9 (56) 41 (59) 
0.86
Marital status 
 Single 5 (31)  38 (54) 
 Married 11 (69)  32 (46) 
0.16
Skin color 
 White 12 (75)  59 (84) 
 Non-white 4 (25)  11 (16) 
0.46
Education 
 < 8 years 2 (12)  22 (32) 
 8 - 11 years  9 (56)  17 (24) 
 > 11 years  5 (32)  31 (44) 
0.04
Menarche 
 <12 years  5 (31)  19 (27) 
	 ≥12	years	old	 11	(69)		 51	(73)	
0.76
Age at first  
 intercourse 
 < 17 years 9 (56)  28 (40) 
 17 - 19 years 2 (13)  22 (31) 0.34 
	 ≥	20	years		 5	(31)		 20	(29)	
No. of lifetime  
 partners 
 > 2 partners 6 (37)  33 (47) 
	 ≤	2	partners	 10	(63)		 37	(53)	
0.67
No. of pregnancies 
	 ≥	3	children	 3	(19)		 33	(47) 
 < 3 children 13 (81)  37 (53) 
0.07
Age at the 1st  
 pregnancy 
	 ≤	17	years	old	 5	(31)		 14	(20) 
 > 18 years old  11 (69)  56 (80) 
0.33
Oral contraceptives  
 use  
 Yes 14 (87)  50 (71) 
 No 2 (13)  20 (29) 
0.22
Sexually transmitted  
 disease 
 Yes 14 (87)  44 (63) 
 No 2 (13) 26 (37) 
0.11
Smoking 
 Yes 2 (13)  19 (27,0) 
 No 14 (87)  51 (73,0) 
0.34
*p-value for the c2 Test.
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PPV, 17.4% (95%CI: 0–35%) and NPV of 81% (95%CI: 
70.5-91.40%). Regarding Ki67, the sensitivity was 50% 
(95%CI: 23-78.0%), specificity, 66% (95%CI: 54-79%), 
PPV de 25% (95CI%: 8.4-42%), and NPV 85% (95%CI: 
75-96%). 
Table 2 describes the distribution of the number of cells 
(%) that expressed both p16INK4a and Ki67 markers.
Studies have shown that the HPV is an important 
factor for the development of cervical precursor lesions 
and cancer; however, cofactors such as age, use of oral 
contraceptives, other hormones, parity, smoking and 
previous exposure to other sexually transmitted agents, 
such as Clamydia trachomatis and herpes simplex virus 
2, have been mentioned.1,14
CT is necessarily an intracellular agent that infects 
epithelial cells of the genital tract and the ocular tis-
sue. It is one of the most common infection worldwide 
with 89 million new cases/year.15 Asymptomatic infec-
tion is common, but nonetheless it is considered as a 
cause of morbidity in sexually active women, causing 
severe sequelae such as pelvic inflammatory disease, 
ectopic pregnancy and tubal infertility. It is also asso-
ciated with hypertrophy and induction of metaplasia, 
suggesting that it may have a role in cervical cancero-
genesis.15 
In addition, there are evidences that HPV-infected 
women present a higher risk to contract another infec-
tion, like CT infection.3 In the present study, the fre-
quency of HPV infection was of 83% and CT infection 
19%. These rates are higher than previous reports,16 pos-
sibly because this was a high risk sample, provided that 
every women had undergone cervical biopsy. A previ-
ous report16 found an 8% prevalence of CT infection and 
significantly associated with high risk HPV (OR = 2.5, 
p < 0.005), especially in women over 41 years old. 
Education was significantly associated with coinfec-
tion in the present study. It maybe suggested that ed-
ucation may interfere in the level of knowledge about 
risk factors, exposure and information about means of 
prevention. A higher risk of infection was also observed 
in the HPV-infected patients.15 In relation to the viral 
types tested, the present study shows that HPV-16 was 
the most frequent high-risk viral type, which is in agree-
ment with other authors.15 
A study17 that enrolled 5,328 women, aged between 
15-44 years, in eight countries presented a CT infec-
tion prevalence of 0.2% (95%CI: 0.0-0.7%) in Spain and 
5.6% (95%CI 3.4-7.8%) in Nigeria, being higher in the 
age range between 15-24 years (4.5, 95%CI: 3.4-8.0%) 
than the age range of 25-44 years (2.6, 95%CI: 2.1-3.1). 
The same investigators17 believe that such prevalence 
data are low and do not express the reality for high-risk 
women.
De Paula et al.18 investigated the presence of CT-
DNA and HPV-DNA in 250 cervical-vaginal samples of 
normal patients or patients with cytological alterations. 
Among them, 70% were negative, 40% were HPV-DNA 
positive and 5.2% had a positive diagnosis of CT infec-
tion. Among samples with abnormal cytology, HPV-
DNA was detected in 73.3% and CT-DNA, in 9.33%. The 
higher coinfection rate, 15.4%, was found in samples 
diagnosed as atypical squamous cells/glandular cells 
of undetermined significance. An association between 
HPV infection and cytological alterations was verified; 
however, for CT infection or coinfection, such associa-
tion was not observed. Taking that into account and re-
lating it to the results found in the present study, it can 
be suggested that the association was not verified due to 
the low number of CT cases. However, it can be noticed 
that only 4/16 (25%) of the cases had coinfection and 
normal histology.
In a study19 with 114 cases, where 72 were incident and 
42 were prevalent at the study entrance, HPV-16 sero-
positivity was associated with cervical cancer (OR = 6.33, 
95% CI: 3.45-11.62). In general, the CT infection was 
not associated with the cervical cancer; however, there 
was an association when incidental cases were evaluated 
(OR = 2.94, 95% CI: 1.16-8.47).19
The p16INK4a expression has been mentioned5,6 
as a promising marker for HR-HPV-induced lesions. 
However, studies did not evaluate if its expression is in-
creased in HPV and CT coinfection. In HPV positive 
Table 2. Number of cells expressing both p16INK4a and Ki67 markers* 
    p16INK4a  
           No expression   ≥ 1 ≤10 cells ≥ 11 ≤ 50 cells ≥ 51 cells
Ki67 Positive 6 (18.7) 0 (0.0%) 4 (12.5%) 22 (68.8%) 
 Negative 20 (37.0%) 4 (7.4%) 12 (21.25%) 18 (33.4%)
*p-value = 0.01 for the association (Fisher’s Exact Test).
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patients, 78.2% expressed the protein, where the in-
tensity was moderate to strong in 54.5% of the cases 
and the pattern was diffuse in 56.4%, as expected. The 
p16INK4a appeared as overexpressed by the interac-
tion of high-risk HPV E7 oncoprotein and the pRb, 
resulting in the release of the E2F transcription fac-
tor. This interaction is analogous to the CDK-mediated 
phosphorylation, resulting in the p16INK4a inhibitor 
accumulation. However, among patients with coinfec-
tion in the present study, the p16INK4a expression oc-
curred in 56.3%. 
Ki67 is a proliferation antigen that has been related 
to carcinogenesis in different tumor types. High-risk 
HPV infections and cell cycle alterations with higher 
Ki67 expression have been mentioned.9,10 CT infec-
tion has been suggested as a risk factor for HPV and, 
consequently for carcinogenesis.3,14 The objective of 
the present study was to verify if coinfection increases 
proliferation, through Ki67 determination in relation 
to HPV infection, provided that studies verifying this 
association were not found in literature. In this study, 
Ki67 was expressed in 50% of the coinfected cases and 
in 34% of the positive cases of HPV-DNA.
Through this immunohistochemical analysis, we had 
intended to investigate if some of these markers or the 
combination of both could suggest a larger association 
in the patients with coinfection. No significant differ-
ence was found in the p16INK4a and Ki67 expression in 
patients with coinfection, in relation to HPV-DNA posi-
tivity alone. Just like the results observed by Fehér and 
Szalmáz,20 our findings suggest that the presence of CT 
infection does not seem to be associated with cervical 
carcinogenesis. Thus, although more than a half of the 
coinfected patients expressed p16INK4a and more than 
one third expressed both markers studied, the results 
suggest no association between these variables. How-
ever, other studies involving larger samples are neces-
sary to corroborate such findings in a more conclusive 
manner. 
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